PHC GroupParent company acquired Epredia through acquisition
Remote hiring company
Remote jobs at Epredia
Improving lives by enhancing precision cancer diagnostics
Healthcare
Company overview
About Epredia
Epredia is a global precision cancer diagnostics company working to improve patient outcomes by providing groundbreaking technologies. Founded in 1937 and established as Epredia in July 2019 through an acquisition by PHC Group from Thermo Fisher Scientific, the company offers a wide breadth of solutions that continue to transform the anatomical pathology market. Powered by trusted brands such as Shandon, Microm, Menzel Gläser and Richard-Allan Scientific, Epredia is committed to improving lives by enabling pathologists through enhanced precision cancer diagnostics.
Purpose
Mission and direction
Epredia is a global precision cancer diagnostics company focused on advancing anatomical pathology and digital pathology technologies that help pathologists improve cancer diagnosis and patient outcomes. Through trusted brands and clinically focused products, the company develops and delivers innovative solutions that support healthcare providers worldwide.
How they work
Company values
- People
- Customer-centric
- Continuous Learning
- Innovation
- Results
Leadership